PortfoliosLab logoPortfoliosLab logo
TMED vs. CNCR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

TMED vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


TMED

1D
1.71%
1M
5.92%
YTD
10.47%
6M
9.58%
1Y
33.64%
3Y*
5Y*
10Y*

CNCR

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. CNCR - Yearly Performance Comparison


Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMED vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMED
TMED Risk / Return Rank: 6666
Overall Rank
TMED Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
TMED Sortino Ratio Rank: 6969
Sortino Ratio Rank
TMED Omega Ratio Rank: 6161
Omega Ratio Rank
TMED Calmar Ratio Rank: 7070
Calmar Ratio Rank
TMED Martin Ratio Rank: 6464
Martin Ratio Rank

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMED vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TMEDCNCRDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.32

Calmar ratioReturn relative to maximum drawdown

3.04

Martin ratioReturn relative to average drawdown

9.95

TMED vs. CNCR - Sharpe Ratio Comparison


Loading charts...

Drawdowns

TMED vs. CNCR - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TMED and CNCR.


Loading charts...

Drawdown Indicators


TMEDCNCRDifference

Max Drawdown

Largest peak-to-trough decline

-11.11%

0.00%

-11.11%

Max Drawdown (1Y)

Largest decline over 1 year

-11.11%

Current Drawdown

Current decline from peak

0.00%

0.00%

0.00%

Average Drawdown

Average peak-to-trough decline

-2.47%

0.00%

-2.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.39%

Volatility

TMED vs. CNCR - Volatility Comparison


Loading charts...

Volatility by Period


TMEDCNCRDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.00%

Volatility (6M)

Calculated over the trailing 6-month period

13.61%

Volatility (1Y)

Calculated over the trailing 1-year period

18.21%

0.00%

+18.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.08%

0.00%

+18.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.08%

0.00%

+18.08%

TMED vs. CNCR - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is lower than CNCR's 0.79% expense ratio.


Dividends

TMED vs. CNCR - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.49%, while CNCR has not paid dividends to shareholders.


PositionTTM2025
CNCR
Loncar Cancer Immunotherapy ETF
0.00%0.00%
TMED
T. Rowe Price Health Care ETF
0.49%0.54%

Frequently Asked Questions


On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.

TMED is cheaper with a 0.44% expense ratio, compared with 0.79% for CNCR.

TMED has the higher dividend yield at 0.49%, compared with 0.00% for CNCR.

They also come from different issuers: T. Rowe Price and Exchange Traded Concepts. Their fees differ too: 0.44% for TMED and 0.79% for CNCR.

Portfolio Optimizer

Find the right allocation for TMED and CNCR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer